000			01828 a2200517 4500
005			20250513090402.0
264		0	_c19960613
008			199606s 0 0 eng d
022			_a0364-5134
024	7		_a10.1002/ana.410390506 _2doi
040			_aNLM _beng _cNLM
100	1		_aIsojärvi, J I
245	0	0	_aObesity and endocrine disorders in women taking valproate for epilepsy. _h[electronic resource]
260			_bAnnals of neurology _cMay 1996
300			_a579-84 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aBody Weight _xdrug effects
650	0	4	_aCarbamazepine _xadverse effects
650	0	4	_aDehydroepiandrosterone _xanalogs & derivatives
650	0	4	_aDehydroepiandrosterone Sulfate
650	0	4	_aEndocrine System Diseases _xchemically induced
650	0	4	_aEpilepsy _xcomplications
650	0	4	_aEvaluation Studies as Topic
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHyperandrogenism _xchemically induced
650	0	4	_aHyperinsulinism _xchemically induced
650	0	4	_aInsulin-Like Growth Factor Binding Protein 1 _xblood
650	0	4	_aInsulin-Like Growth Factor I _xdrug effects
650	0	4	_aObesity _xchemically induced
650	0	4	_aPolycystic Ovary Syndrome _xchemically induced
650	0	4	_aPrevalence
650	0	4	_aSex Hormone-Binding Globulin _xmetabolism
650	0	4	_aSomatomedins _xdrug effects
650	0	4	_aTestosterone _xblood
650	0	4	_aTime Factors
650	0	4	_aValproic Acid _xadverse effects
700	1		_aLaatikainen, T J
700	1		_aKnip, M
700	1		_aPakarinen, A J
700	1		_aJuntunen, K T
700	1		_aMyllylä, V V
773	0		_tAnnals of neurology _gvol. 39 _gno. 5 _gp. 579-84
856	4	0	_uhttps://doi.org/10.1002/ana.410390506 _zAvailable from publisher's website
999			_c8618587 _d8618587